Interactive Coding Equipment has produced a detailed guide to help pharmaceutical manufacturers make informed choices in the selection of suitable coding equipment for their applications.
Interactive Coding Equipment (ICE), a supplier of coding and marking solutions, has produced a detailed guide to help pharmaceutical manufacturers make informed choices in the selection of suitable coding equipment for their applications.
According to ICE, many manufacturers will have to review their coding operations in light of the upcoming European Falsified Medicines Directive (FMD). The new ICE pharmaceutical guide explains the principles of serialization and how it can deliver effective traceability in the fight against counterfeiting.
The guide reviews the different coding technologies available such as thermal transfer, thermal inkjet, continuous inkjet, laser, case coders, and label print applicators, and their suitability for the demands of pharmaceutical coding. It also lists the key considerations for pharmaceutical manufacturers when selecting a coding solution. The importance of a common operating system is emphasized. The guide covers key performance criteria such as speed, “last label” capability for label print applicators, and the ability to produce an audit trail, all of which are essential to achieving effective serialization.
ICE notes that most pharmaceutical companies operate globally. Being part of such a highly regulated industry means that the type of codes required by pharmaceutical manufacturers may have wider implications and also affect the selection of the right coder.
“Without an effective coding system, pharmaceutical manufacturers are unable to operate internationally and so they cannot afford to make the wrong decisions when selecting their equipment,” commented ICE managing director Chris Simpson in a press statement. He said that the ICE pharmaceutical guide has been developed to provide impartial advice to help companies make the right choices.
The pharmaceutical guide can be downloaded at www.interactivecoding.co.uk/pharma-guide/.
The ICE barcode and secondary packaging guides can be viewed and downloaded at www.interactivecoding.co.uk/resources/guides.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.